Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/27/2000EP0751768B1 Anti-viral and anti-cancer agent
12/27/2000EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides
12/27/2000EP0671909B1 Syndecan stimulation of cellular differentiation
12/27/2000EP0627924B1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
12/27/2000CN1278301A Procine circoviruses, vaccines and diagnostic reagents
12/27/2000CN1278300A Multivalent antigen-binding proteins
12/27/2000CN1278299A Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
12/27/2000CN1278267A Human thrombopoietin produced established human ccell lines, process for producing same, and medicinal compositions contg. same
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1278184A Preventives or remedies for ischemic diseases
12/27/2000CN1278183A Soluble MHC complexes and methods of use thereof
12/27/2000CN1278177A Neovascularization promoters
12/27/2000CN1278175A Compositions of lipid lowering agents
12/27/2000CN1278173A Skin penetration enhancing components
12/27/2000CN1278007A Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and use thereof
12/27/2000CN1277996A Novel polypeptide-human galactose transferase 40, and polynucleotide for coading same
12/27/2000CN1277995A Novel polypeptide-human cell pigment oxidase related protein 37, and polynucleotide for coding same
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277873A Application of VMIP derivatives in medicine for treating AIDS and inflammation pathology
12/27/2000CN1059929C Human thymosin alpha-source and preparing method thereof
12/27/2000CN1059926C Glucokinase gene and its high expression engineering strain
12/26/2000US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
12/26/2000US6166217 Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
12/26/2000US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166192 PGC-1, a novel brown fat PPARγ coactivator
12/26/2000US6166191 Nucleotide sequences coding cancer protein; for diagnosis and detection of cell proliferative and developmental defects
12/26/2000US6166186 Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166086 Small molecules that increase the conversion of food to body weight gain
12/26/2000US6166039 Peripherally active anti-hyperalgesic opiates
12/26/2000US6165992 Histidine kinase
12/26/2000US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae
12/26/2000US6165990 Use of antisense gastrin expression to reduce colon cancer growth
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165983 Use of collagen for the treatment of degenerative articular processes
12/26/2000US6165982 Adding an effective amount of natural sericin a protein obtained from silkworm cocoon or raw silkworm to tyrosine and lipid peroxide containing system to prevent discoloration or coloration due to oxidation activity
12/26/2000US6165979 Glutathion disulfide which is an oxidized glutathion when administered parenteral induces the endogenous cytokine and/or hematopoietic factor; used for neoplastic, infectious, hematologic, immunologic or other diseases
12/26/2000US6165978 Wound healing composition
12/26/2000US6165977 Isozyme-specific activators of protein kinase C methods and compositions
12/26/2000US6165976 Therapeutic preparation for inhalation
12/26/2000US6165975 Microdose therapy
12/26/2000US6165974 Administering an effective dose of a pharmaceutical preparation comprising at least two coagulation factors which are components of a prothrombinase or of a pro-prothrombinase to the patient for the treatment of acute bleeding
12/26/2000US6165794 Suppression of proteolytic activity by dysfunctional protease formation
12/26/2000US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents
12/26/2000US6165790 Antisense modulation of PI3 kinase p55 gamma expression
12/26/2000US6165789 Antisense modulation of hnRNP A1 expression
12/26/2000US6165787 Regulated transcription of targeted genes and other biological events
12/26/2000US6165786 Antisense modulation of nucleolin expression
12/26/2000US6165781 Nucleotide sequences comprising an inverted terminal duplication and heterologous nucleotide sequences; for the treatment of genetic disorders and gene therapy
12/26/2000US6165779 Recombinant virus vector such as tumor suppressor gene formulated in a buffer comprising a detergent; for gene therapy of cancer; buffer comprising a delivery-enhancing agent
12/26/2000US6165772 Simple and cost-effective preparation of vehicle for delivery of dna, rna, protein, peptide nucleic acids, or lipophilic drugs
12/26/2000US6165771 Compounds
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165764 Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165755 Chicken neuropeptide gene useful for improved poultry production
12/26/2000US6165754 Method of expressing an exogenous nucleic acid
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs
12/26/2000US6165747 Comprise morphogenic signals produced by tissue patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates
12/26/2000US6165738 Hybrid of two human isoforms; for recombinant production; for diagnosis, presymptomatic detection, and prevention of insulin dependent diabetes mellitus
12/26/2000US6165735 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165728 Nucleotide sequences which hybridize to gene and inhibit gene expression of human adaptor protein involved in signal transduction; diagnosis, therapy, and prophylaxis of related diseases
12/26/2000US6165719 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
12/26/2000US6165712 Contacting a cell with an exogenous molecule effective to modulate gene expression and affect level of protein thus pathological effect; molecule binds to regulatory sequence, rna, or transcription regulating protein; viricides
12/26/2000US6165514 Group iiia element-containing compounds mimic the beneficial biological effects of transforming growth factor beta without side effect, therefore applied directly to the bandage or dressing for wound healing
12/26/2000US6165508 Controlled release of metal cation-stabilized interferon
12/26/2000US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same
12/26/2000US6165496 A sheet formed of cross-linked keratin not requiring a binding agent, bound together by reformed disulfide linkage and hydrogen bond, used as wound healing dressing, preferred use is as tissue engineering cell scaffold for grafting
12/26/2000US6165487 Useful for treatment of tissue defects in tissues such as bone, cartilage, and muscle.
12/26/2000US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide
12/26/2000US6165476 Fusion proteins with an immunoglobulin hinge region linker
12/26/2000US6165472 Folyl-polyglutamate synthetase (fpgs) of s. pnuemoniae is necessary for a fully functional folate synthesis pathway. having a present benefit of being useful to screen compounds for antibiotic activity.
12/26/2000US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus.
12/26/2000US6165466 Antagonists of interleukin-15
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000US6165459 Methods for suppressing myeloid cells with chemokines
12/26/2000US6165458 Composition and method for dermal and transdermal administration of a cytokine
12/26/2000US6165440 Radiation and nanoparticles for enhancement of drug delivery in solid tumors
12/26/2000CA2182476C Macrocyclic difluorostatone derivatives useful as antiviral agents
12/26/2000CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them
12/21/2000WO2000077262A1 Synthetic ligation reassembly in directed evolution
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077252A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene
12/21/2000WO2000077250A2 Method for circularizing oligonucleotides around a double stranded nucleic acid, resulting structures and uses thereof
12/21/2000WO2000077238A1 Heterodimeric opioid g-protein coupled receptors
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
1 ... 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 ... 3163